Lung Cancer Europe (LuCE)

LuCE’s vision is that all Europeans impacted by lung cancer will have equitable access to optimal care, ensuring the best possible outcomes and quality of life. Its work revolves around three key pillars: awareness, advocacy, and education.

Its objectives are to: (i) increase access to early and accurate diagnosis of lung cancer; (ii) improve equity of access to optimal lung cancer treatments and care; (iii) strengthen the lung cancer patient voice; (iv) destigmatise the disease by changing the narrative around lung cancer; and (v) build a strong and sustainable organisation.

LuCE’s objectives align with All.Can’s goal of delivering efficient cancer care. All.Can’s focus on what really matters to people impacted by cancer and to society runs through all of the organisation’s work, underlining the many commonalities between LuCE and All.Can.

LuCE has expertise in developing and delivering patient-driven research through surveys and projects, and is particularly interested in cancer care efficiency, as this contributes to delivering better quality care. Given the complexity of lung cancer and the challenges in accessing biomarker testing and innovative treatments, LuCE is also keen to collaborate on data initiatives, as these can help inform real-world evidence.